Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Predictive Oncology
AddedFeb 19, 2024
UpdatedJun 18, 2026
Predictive Oncology

Predictive Oncology

Public

AI-driven personalized cancer therapy developer, Predictive Oncology, innovates targeted treatments via data-rich patient tumors.

HQ
Eagan, MN, US
Founded
2002
Overview
Compare
Fundraising
Employees
Website

Predictive Oncology, founded with a mission to revolutionize cancer treatment, leverages artificial intelligence to personalize therapies based on data from patient tumors. The company operates through three segments—Skyline, Helomics, and Soluble Biotech—and includes four subsidiaries: Helomics, TumorGenesis, Skyline Medical, and Soluble Biotech. These divisions work collaboratively to enhance drug discovery and development, focusing on improving clinical trial success rates and developing targeted therapies in partnership with pharmaceutical companies.

Notable figures affiliated with Predictive Oncology include experts in AI and oncology, though specific names are not provided. The company has achieved significant milestones in integrating machine learning with scientific research, thereby advancing the precision and efficacy of cancer treatments. Its impact is evident in its collaborations with biopharma partners and its contributions to pre-clinical drug discovery, positioning Predictive Oncology as a key player in the personalized medicine landscape.

Predictive Oncology - Similar Companies

OncoPrecision logo

OncoPrecision

oncoprecision.bio

Precision Health AI logo

Precision Health AI

Onc.AI logo

Onc.AI

onc.ai

Helomics logo

Helomics

Empiri logo

Empiri

empiricancer.com

First Ascent Biomedical logo

First Ascent Biomedical

firstascentbio.com

Triomics logo

Triomics

triomics.com

D2G Oncology logo

D2G Oncology

d2g-oncology.com

xCures logo

xCures

xcures.com

Palm Therapeutics logo

Palm Therapeutics

Vysioneer logo

Vysioneer

vysioneer.com

PredxBio logo

PredxBio

predxbio.com

GenomOncology logo

GenomOncology

genomoncology.com

Certis Oncology Solutions logo

Certis Oncology Solutions

certisoncology.com

Pbs-Bio logo

Pbs-Bio

Predictive Oncology - Quick Facts

Who are Predictive Oncology's competitors?

Companies similar to Predictive Oncology include OncoPrecision, Precision Health AI, Onc.AI and Helomics.

When was Predictive Oncology founded?

Predictive Oncology was founded in 2002.

Where is Predictive Oncology's headquarters located?

Predictive Oncology's headquarters is located in Eagan, MN, US.

When was Predictive Oncology's last funding round?

Predictive Oncology's most recent funding round was for $21.3M (USD) in June 2021.

How much has Predictive Oncology raised to-date?

As of Jun 14, 2021, Predictive Oncology has raised a total of $77.6M (USD).

How many employees does Predictive Oncology have?

Predictive Oncology has 31 employees as of Feb 6, 2024.

Predictive Oncology - Classification

Ownership
  • Public
Technology
  • AI
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapy
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3842Orthopedic, Prosthetic, And Surgical Appliances And Supplies
ISIC
  • 1709Manufacture of other articles of paper and paperboard
  • 2660Manufacture of irradiation, electromedical and electrotherapeutic equipment
Show 32 more industry codes
NAICS
  • 320000Manufacturing
  • 322000Paper Manufacturing
  • 322200Converted Paper Product Manufacturing
  • 322290Other Converted Paper Product Manufacturing
  • 322291Sanitary Paper Product Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339113Surgical Appliance and Supplies Manufacturing
  • 339990All Other Miscellaneous Manufacturing
  • 339999All Other Miscellaneous Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 339900Other Miscellaneous Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research